Horizon Pharma CEO Timothy Walbert's 2019 pay slips 17% to $14M

Horizon Pharma reports 2019 executive compensation

By ExecPay News

Published: March 17, 2022

Horizon Pharma reported fiscal year 2019 executive compensation information on March 17, 2022.
In 2019, nine executives at Horizon Pharma received on average a compensation package of $5.1M, a 24% decrease compared to previous year.
Average pay of disclosed executives at Horizon Pharma
Timothy P. Walbert, Chief Executive Officer, received $14M in total, which decreased by 17% compared to 2018. 66% of Walbert's compensation, or $9.1M, was in stock awards. Walbert also received $3.4M in non-equity incentive plan, $1.1M in salary, as well as $227K in other compensation.
For fiscal year 2019, the median employee pay was $250,565 at Horizon Pharma. Therefore, the ratio of Timothy P. Walbert's pay to the median employee pay was 55 to one.
Barry J. Moze, Chief Administrative Officer, received a compensation package of $4.7M, which increased by 71% compared to previous year. 69% of the compensation package, or $3.2M, was in stock awards.
Paul W. Hoelscher, Chief Financial Officer, earned $4.4M in 2019, a 37% decrease compared to previous year.
Robert F. Carey, Former Executive Vice President, Chief Business Officer, received $4.4M in 2019, which decreases by 37% compared to 2018.
Shao-Lee Lin, Chief Scientific Officer, earned $4.4M in 2019, a 37% decrease compared to previous year.
Vikram Karnani, Executive Vice President, Chief Commercial Officer, received $4.1M in 2019, which increases by 60% compared to 2018.
Jeffrey W. Sherman, M.D., FACP, Chief Medical Officer, earned $3.6M in 2019, a 3% decrease compared to previous year.
Brian K. Beeler, General Counsel, received $3.2M in 2019.
Andy Pasternak, Executive Vice President, Chief Strategy Officer, earned $2.9M in 2019.

Related executives

Brian Beeler

Horizon Pharma

General Counsel

Timothy Walbert

Horizon Pharma

Chief Executive Officer

Paul Hoelscher

Horizon Pharma

Chief Financial Officer

Barry Moze

Horizon Pharma

Chief Administrative Officer

Vikram Karnani

Horizon Pharma

Executive Vice President, Chief Commercial Officer

Shao-Lee Lin

Horizon Pharma

Chief Scientific Officer

Robert Carey

Horizon Pharma

Former Executive Vice President, Chief Business Officer

Andy Pasternak

Horizon Pharma

Executive Vice President, Chief Strategy Officer

You may also like

Source: SEC filing on March 17, 2022.